[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2018/69863,2018,A1Locationinpatent:Page/Pagecolumn209
1120-95-2
141-30-0
1379240-74-0
82278-95-3 | 3-(3-Bromophenyl)-2-[(tert-butoxycarbonyl)amino]propanoic acid | AA003ACY | MFCD01317710
862170-55-6 | (4,6-Dichloropyridin-3-yl)(4-fluorophenyl)methanone | AA003AI7 | MFCD31543873
583052-21-5 | 2-(2,4-Difluorophenyl)-5-methylpyridine | AA003AO8 | MFCD17170319
797-63-7 | Levonorgestrel | AA003AUK | MFCD00199013
6770-38-3 | 1,4-Bis(methoxymethyl)benzene | AA003AXO | MFCD00025903
5580-80-3 | 2,3,4,5-Tetrafluoroaniline | AA003B0O | MFCD00025153
41825-73-4 | 2-Bromo-4,6-dimethylaniline | AA003B3N | MFCD00047826
22364-68-7 | 2-Methylbenzyl cyanide | AA003B6F | MFCD00001904
94133-41-2 | (+)-Menthoxyacetic acid | AA003BAD | MFCD00077813
67333-70-4 | (1S,2S)-(-)-1,2-Cyclohexanediamine D-tartrate | AA003BFQ | MFCD00191980